Kinesin light chains (KLCs) are pivotal components of the kinesin motor protein complex, essential for the transport of various cargoes along the microtubule networks within cells. These chains are not just passive adapters but actively participate in translating chemical energy into mechanical force, effectively enabling the distribution of organelles, proteins, and vesicles to their proper intracellular destinations. KLC proteins are encoded by a family of genes whose expression can be fine-tuned by cellular demands and environmental cues. The intricate regulation of KLCs is critical for maintaining cellular homeostasis and adapting to changes within the cell's internal and external environment. For example, during periods of increased cellular activity or stress, the expression of KLCs may be upregulated to meet the heightened demand for intracellular transport. This upregulation ensures that essential materials are delivered promptly to where they are most needed, thereby supporting the dynamic nature of cellular functions.
A diverse array of chemical compounds has been identified that can potentially induce the expression of KLC proteins. These activators operate through various cellular mechanisms, initiating cascades of molecular events that culminate in the increased transcription of KLC genes. For instance, certain compounds can stimulate pathways that converge on the nucleus, prompting the recruitment of transcription factors to the promoters of KLC genes. Other activators may alter the epigenetic landscape, decreasing the compactness of chromatin around these genes, thereby granting the transcriptional machinery greater access to DNA. Moreover, some chemicals might act indirectly by setting off stress responses that, in turn, initiate a broader upregulation of genes, including those coding for KLC proteins. Collectively, these activators underscore the complexity of cellular control systems and highlight the diverse strategies cells employ to upregulate vital components like KLCs in response to various stimuli. Through the concerted action of these mechanisms, cells are able to modulate the expression of KLC proteins, ensuring efficient intracellular transport and the maintenance of cellular function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, which can initiate the transcription of genes including those coding for KLC by altering DNA conformation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises cAMP levels, which in turn activate protein kinase A, leading to the phosphorylation of transcription factors that stimulate KLC gene transcription. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
This hormone binds estrogen receptors, which dimerize and bind to estrogen response elements, initiating transcription processes that include KLC gene upregulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A causes a more relaxed chromatin structure, facilitating access for transcription machinery to KLC gene promoters. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can activate the Wnt/β-catenin pathway, leading to the accumulation of β-catenin in the nucleus, where it can promote KLC gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate inhibits histone deacetylases, leading to hyperacetylation of histones, which enhances transcription of several genes, possibly including those for KLC. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C, which then phosphorylates target transcription factors, potentially resulting in the elevated transcription of the KLC gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a demethylating agent, 5-Azacytidine can remove methyl groups from DNA, which may reverse silencing of genes and promote the transcription of KLC. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone binds to glucocorticoid receptors, which may bind to glucocorticoid response elements in the KLC gene promoter region, enhancing its transcription. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin triggers the unfolded protein response in the endoplasmic reticulum, which can lead to the activation of transcription factors that stimulate KLC gene expression. | ||||||